Skip to main content
For Healthcare Professionals
TH-Jrdiance-bg
IN PATIENTS WITH TYPE 2 DIABETES
WITH HIGH CV RISK

CV DEATH HAS A NEW OPPONENT

Jardiance® (empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease

Click to view  prescribing information

EFFICACY

What is JARDIANCE® (empagliflozin)?

JARDIANCE® (empagliflozin) tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.

JARDIANCE® (empagliflozin) tablets are indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

Important safety information

What is the most important information I should know about JARDIANCE® (empagliflozin)

  • Dehydration
  • Ketoacidosis
  • Urinary tract infections
  • Genital tract infections

Who should not use JARDIANCE® (empagliflozin) 

  • Type 1 DM
  • Patients with persistent eGFR<45 ml/min/1.73 m2